UOA researchers working on weight-loss treatment that won't suppress appetite
University of Auckland researchers are developing a new obesity treatment that targets fat storage rather than appetite suppression. The oral drug aims to burn fat more efficiently before it accumulates in the body.
Why it matters
Represents a potential shift in medical approaches to obesity management, offering an alternative to current GLP-1 receptor agonists.
Researchers at the University of Auckland are developing an obesity treatment designed to help people lose weight without suppressing appetite.
Unlike other treatments such as Wegovy and Mounjaro, this would would target the body's fat-storage process and burn it in a different way.
Auckland University Molecular Medicine and Pathology professor Peter Shepherd says this treatment will burn off fat faster and reduce it before it has time to 'settle in'.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in